SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001387131-12-001510
Filing Date
2012-05-11
Accepted
2012-05-11 16:58:03
Documents
11
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT txmd-10q_033112.htm 10-Q 623645
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex-31_1.htm EX-31.1 16260
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER ex-31_2.htm EX-31.2 16873
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex-32_1.htm EX-32.1 7739
5 CERTIFICATION OF CHIEF FINANCIAL OFFICER ex-32_2.htm EX-32.2 7715
  Complete submission text file 0001387131-12-001510.txt   2057115

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT txmd-20120331.xml EX-101.INS 205999
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT txmd-20120331.xsd EX-101.SCH 14720
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT txmd-20120331_cal.xml EX-101.CAL 26020
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT txmd-20120331_def.xml EX-101.DEF 8762
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT txmd-20120331_lab.xml EX-101.LAB 103026
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT txmd-20120331_pre.xml EX-101.PRE 68929
Mailing Address 951 BROKEN SOUND PARKWAY NW SUITE 320 BOCA RATON FL 33487
Business Address 951 BROKEN SOUND PARKWAY NW SUITE 320 BOCA RATON FL 33487 516-961-1911
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

IRS No.: 870233535 | State of Incorp.: UT | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-16731 | Film No.: 12835343
SIC: 2834 Pharmaceutical Preparations